Hydroxyapatite Implants Research Articles

Clinical characterization and long-term postoperative outcomes of retinoblastoma patients receiving enucleation and primary orbital implantation in early infancy: an observational study

ObjectivesTo retrospectively investigate clinical characterization and the long-term postoperative outcomes of retinoblastoma (RB) patients receiving enucleation with primary orbital implantation in early infancy (0–6 months old).MethodsThe clinical and follow-up data of 42 RB patients receiving enucleation with primary orbital implantation in early infancy at Beijing Tongren Hospital from December 2009 to January 2020 were analysed. The average follow-up time was 83 months. The patient group included 24 males and 18 females, 30 unilateral and 12 bilateral cases. A total of 44 eyes with 10 in stage D and 34 in stage E underwent 40 unilateral and 2 bilateral surgeries. 17 RB eyes received hydrogel and 27 RB eyes received hydroxyapatite implants. This study was performed by following the guideline of STROBE.ResultsEnucleation combined with primary orbital implantation promoted survival and was safe with few and minor complications such as increased secretion, upper eyelid ptosis, and sunken eye sockets which were not affected by stages, lateralities, or implant materials. 55-80% RB patients exhibited satisfactory appearance and obvious or moderate motility of orbital implants according to the evaluation by doctors and family members. Family members were likely more optimistic about the appearance and more pessimistic about motility of the orbital implantation than doctors did.The quality of life was high as indicated by PedsQL3.0 or PedsQL4.0 scores ( ≧ 90 for > 75% patients). It was not affected by the stages, laterality, and implant materials, nor affected by the appearance and motility of the implants.ConclusionsThe outcomes of the combination of enucleation and primary orbital implantation for pertinent RB patients in early infancy are generally satisfactory with few and minor complications, high safety, appearance, and overall quality of life. Enucleation combined with primary orbital implantation in early infancy benefits pertinent RB patients in appearance, survival, and quality of life.

Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma.

Osteosarcoma treatment comprises pre-surgical chemotherapy followed by radical surgery and further chemotherapy cycles, but the prognosis has been far from satisfactory. No new drugs or treatment modalities have been developed for clinical use in the last four decades. We describe a nano-hydroxyapatite (HA)-based local drug delivery platform for the delivery of doxorubicin (DOX), a cornerstone drug in osteosarcoma treatment. The efficacy of the developed drug delivery system was evaluated in an orthotopic human osteosarcoma xenograft in the proximal tibia of mice. After tumor development, the tumor was surgically resected and the void filled with the following: (1) No treatment (G1); (2) nHA only (G2); (3) DOX-loaded nHA (G3). In-vivo tumor response was assessed by evaluating the tumor-induced osteolysis at 2 weeks using micro-CT followed by in-vivo PET-CT at 3 weeks and ex-vivo micro-CT and histology. Micro-CT imaging revealed complete destruction of the tibial metaphysis in groups G1 and G2, while the metaphysis was protected from osteolysis in G3. PET-CT imaging using 18F-FDG revealed high metabolic activity in the tumors in G1 and G2, which was significantly reduced in G3. Using histology, we were able to verify that local DOX delivery reduced the bone destruction and the tumor burden compared with G1 and G2. No off-target toxicity in the vital organs could be observed in any of the treatment groups histologically. This study describes a novel local drug adjuvant delivery approach that could potentially improve the prognosis for patients responding poorly to the current osteosarcoma treatment.

Assessment of cranial reconstruction utilizing various implant materials: finite element study

The human head can sometimes experience impact loads that result in skull fractures or other injuries, leading to the need for a craniectomy. Cranioplasty is a procedure that involves replacing the removed portion with either autologous bone or alloplastic material. While titanium has traditionally been the preferred material for cranial implants due to its excellent properties and biocompatibility, its limitations have prompted the search for alternative materials. This research aimed to explore alternative materials to titanium for cranial implants in order to address the limitations of titanium implants and improve the performance of the cranioplasty process. A 3D model of a defective skull was reconstructed with a cranial implant, and the implant was simulated using various stiff and soft materials (such as alumina, zirconia, hydroxyapatite, zirconia-reinforced PMMA, and PMMA) as alternatives to titanium under 2000N impact forces. Alumina and zirconia implants were found to reduce stresses and strains on the skull and brain compared to titanium implants. However, PMMA implants showed potential for causing skull damage under current loading conditions. Additionally, PMMA and hydroxyapatite implants were prone to fracture. Despite these findings, none of the implants exceeded the limits for tensile and compressive stresses and strains on the brain. Zirconia-reinforced PMMA implants were also shown to reduce stresses and strains on the skull and brain compared to PMMA implants. Alumina and zirconia show promise as alternatives to titanium for the production of cranial implants. The use of alternative implant materials to titanium has the potential to enhance the success of cranial reconstruction by overcoming the limitations associated with titanium implants.Graphical

Comparative Analysis of Osteointegration in Hydroxyapatite and Hydroxyapatite-Titanium Implants: An In Vivo Rabbit Model Study.

The study evaluates the osteointegration of hydroxyapatite (HAp) and hydroxyapatite-titanium (HApTi) biocomposites implanted in the femurs of rabbits. The biocomposites were fabricated using powder metallurgy and subjected to a two-step sintering process. Scanning electron microscopy (SEM) was employed to analyze the morphology, while mesenchymal stem cells were cultured to assess cytotoxicity and proliferation. In vivo experiments involved the implantation of HAp in the left femur and HApTi in the right femur of twenty New Zealand white rabbits. Computed tomography (CT) scans, histological, immunohistochemical, and histomorphometric analyses were performed to assess bone density and osteoblast activity. Results demonstrated that HApTi implants showed superior osteointegration, with higher peri-implant bone density and increased osteoblast count compared to HAp implants. This study concluded that HApTi biocomposites have potential for enhanced bone healing and stability in orthopedic applications.

Assessment of stability of early loaded nano-coated hydroxyapatite implants in posterior maxilla

Assessment of stability of early loaded nano-coated hydroxyapatite implants in posterior maxilla

Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation

Fracture fixation in an ageing population is challenging and fixation failure increases mortality and societal costs. We report a novel fracture fixation treatment by applying a hydroxyapatite (HA) based biomaterial at the bone-implant interface and biologically activating the biomaterial by systemic administration of a bisphosphonate (zoledronic acid, ZA). We first used an animal model of implant integration and applied a calcium sulphate (CaS)/HA biomaterial around a metallic screw in the tibia of osteoporotic rats. Using systemic ZA administration at 2-weeks post-surgery, we demonstrated that the implant surrounded by HA particles showed significantly higher peri‑implant bone formation compared to the unaugmented implants at 6-weeks. We then evaluated the optimal timing (day 1, 3, 7 and 14) of ZA administration to achieve a robust effect on peri‑implant bone formation. Using fluorescent ZA, we demonstrated that the uptake of ZA in the CaS/HA material was the highest at 3- and 7-days post-implantation and the uptake kinetics had a profound effect on the eventual peri‑implant bone formation. We furthered our concept in a feasibility study on trochanteric fracture patients randomized to either CaS/HA augmentation or no augmentation followed by systemic ZA treatment. Radiographically, the CaS/HA group showed signs of increased peri‑implant bone formation compared with the controls. Finally, apart from HA, we demonstrated that the concept of biologically activating a ceramic material by ZA could also be applied to β-tricalcium phosphate. This novel approach for fracture treatment that enhances immediate and long-term fracture fixation in osteoporotic bone could potentially reduce reoperations, morbidity and mortality. Statement of significance• Fracture fixation in an ageing population is challenging. Biomaterial-based augmentation of fracture fixation devices has been attempted but lack of satisfactory biological response limits their widespread use. • We report the biological activation of locally implanted microparticulate hydroxyapatite (HA) particles placed around an implant by systemic administration of the bisphosphonate zoledronic acid (ZA). The biological activation of HA by ZA enhances peri‑implant bone formation. •Timing of ZA administration after HA implantation is critical for optimal ZA uptake and consequently determines the extent of peri‑implant bone formation. • We translate the developed concept from small animal models of implant integration to a proof-of-concept clinical study on osteoporotic trochanteric fracture patients. • ZA based biological activation can also be applied to other calcium phosphate biomaterials.

Long-Term Follow-Up of Custom-Made Porous Hydroxyapatite Cranioplasties: Analysis of Infections in Adult and Pediatric Patients.

In neurosurgery, cranioplasty (CP) stands as a pivotal surgical intervention, particularly following head trauma or various neurosurgical interventions. This study scrutinizes the intricacies of CP, emphasizing its prevalence and associated complications, with a specific focus on custom-made porous hydroxyapatite (PHA) implants. The investigation spans 687 patients (with 80 patients of pediatric age, less than 14 years old) across 26 neurosurgical centers in five European countries. Methodologically, this study delves into patient characteristics, complications, and infection data through a comprehensive post-marketing on-site surveillance approach. Notably, infections emerged as the primary complication, affecting 41 patients (6% of implants) with a clear distinction in onset patterns between pediatric (with more infections, 10% versus 5.4% in adults and an earlier onset of complications) and adult populations. Out of these 41 cases, cranioplasty explantation was required in 30 patients, 4.4% of the total population. Furthermore, bifrontal decompression correlated with a significantly elevated infection risk as compared to unilateral decompression (12.5% versus 5.1%) which remains after the examination of possible confounding factors. These findings provide substantial insights into the complexities of CP, suggesting the necessity for tailored strategies in pediatric and adult cases and cautioning against bifrontal decompressions. Despite acknowledging limitations and calling for prospective studies with long term follow-up, this research advances our understanding of the use of PHA CP, guiding clinical decision-making and emphasizing the importance of customized approaches for diverse patient cohorts.

Comparative Analysis of Surface Modification Techniques for Assessing Oral Implant Osseointegration: An Animal Study.

Effective implant placement depends critically on the implant's level of osseointegration with the alveolar bone. To increase osseointegration during implant placement, research has concentrated on the surface modificationof implants, and morphological analyses have looked at the thread pattern in close interaction with the bone's surface. This study aimed to assess and compare the extent of oral implant osseointegration in different surface modification techniques. In this study, 12 healthy adult dogs aged 18-24 months were used. Tooth extractions were performed on both sides of the mandible, and wounds were closed with sutures. Two months later, the right mandible of each dog underwent local anesthesia and general anesthesia. Four different implant types were placed based on their surface treatments: resorbable blast media (RBM)-treated implants, hydroxyapatite (HA) implants with an ultra-thin HA film, hydrothermal-treated HA implants coated with HA, and sandblasting combined acid etching (SLA) implants treated with plasma spray and acid etching. A total of 48 implants were divided into two- and four-week groups, with identical dimensions. Each dog received two implants from each group, for a total of eight implants per dog. The implants were securely placed into the superior alveolar bone with a torque greater than 35-N up to a depth of 1 mm. Periotest M (Medizintechnik Gulden e.K., Modautal, Germany) was used to calculate the periotest value (PTV) as a typical value on the buccal side of each implant immediately following placement and sacrifice to test the main fixation and stability of the implants. Resonance frequency analysis (RFA) was utilised by Osstell Mentor (Osstell AB, Gothenburg, Sweden) to simultaneously assess the implant stability quotient (ISQ) on the medial, distal, buccal, and lingual sides of the implant. The rotational torque in one of the sacrificed dogs was calculated using the MGT 50 (ELECTROMATIC Equipment Co., Inc., New York, USA) torque analyzer. The histomorphometric evaluation was performed using an optical microscope (Olympus Corporation, Tokyo, Japan). The upper half's bone-implant contact (BIC), which was found to be more important for implant stability, was studied together with the ratio of the new bone formation area (NBFA) to the complete implant. The maximum stability was observed in HA-treated implants in the fourth week. The minimum stability was observed in hydrothermal-treated HA implants in the fourth week. The stability in each group was greater in the four-week evaluation as compared to the two-week evaluation. The stability was satisfactory in almost all implants at two- and three-week evaluations. The maximum value of the percentage area of newly formed bone at the two- and four-week evaluations was observed in HA-treated implants. The minimum value of the percentage of the area of newly formed bone at two- and four-week evaluations was observed in SLA and RBM-treated implants respectively. The difference was significant statistically (p ≤ 0.05). All implant surface modifications, in general, produced satisfactory osseointegration. Excellent osseointegration was seen in the upper portion of the implant with hydrothermally treated HA.

Effect of Surface Chemistry on Hemolysis, Thrombogenicity, and Toxicity of Carbon Nanotube Doped Thermally Sprayed Hydroxyapatite Implants.

Assessing blood compatibility is crucial before in vivo procedures and is considered more reliable than many in vitro tests. This study examines the physiochemical properties and blood compatibility of bioactive powders ((0.5-2 wt % carbon nanotube (CNT)/alumina)-20 wt %)) produced through a heterocoagulation colloidal technique followed by ball milling with hydroxyapatite (HAp). The 1 wt % CNT composite demonstrated a surface charge ∼5 times higher than HAp at pH 7.4, with a value of -11 mV compared to -2 mV. This increase in electrostatic charge is desirable for achieving hemocompatibility, as evidenced by a range of blood compatibility assessments, including hemolysis, blood clotting, platelet adhesion, platelet activation, and coagulation assays (prothrombin time (PT) and activated partial thrombin time (aPTT)). The 1 wt % CNT composite exhibited hemolysis ranging from 2 to 7%, indicating its hemocompatibility. In the blood clot investigation, the absorbance values for 1-2 wt % CNT samples were 0.927 ± 0.038 and 1.184 ± 0.128, respectively, indicating their nonthrombogenicity. Additionally, the percentage of platelet adhered on the 1 wt % CNT sample (∼5.67%) showed a ∼2.5-fold decrement compared to the clinically used negative control, polypropylene (∼13.73%). The PT and aPTT experiments showed no difference in the coagulation time for CNT samples even at higher concentrations, unlike HAC2 (80 mg). In conclusion, the 1 wt % CNT sample was nontoxic to human blood, making it more hemocompatible, nonhemolytic, and nonthrombogenic than other samples. This reliable study reduces the need for additional in vitro and in vivo studies before clinical trials, saving time and cost.

Assessment of Stability of Early Loaded Nano Coated Hydroxyapatite Implants in Posterior Maxilla

Aim: The aim of the study was to assess the stability after early loading of nano coated hydroxyapatite implants in posterior maxilla. Methodology: This study was conducted on nine patients with at least a missing one maxillary posterior tooth. Ten Nano-coated hydroxyapatite implants (ETIII NH implant by Hiossen) were inserted in nine patients, and then subjected to early loading according to the secondary stability readings taken by Osstell®. Implant stability was measured at the time of implant insertion (T0), 4 (T1), 6 (T1 modified), weeks, and 4 months (T2) post-operative. Cone-beam computed tomography (CBCT) was performed in all patients before starting the treatment. Nine implants healed well except for one implant that failed due to infection. Results: Secondary stability results after 6 weeks of implant incretion were sufficient enough for implant loading, there was significant difference (F= 12.642, DF 3, P value <0.001) among T0, T1, T1 modified, and T2. Conclusion: Nano-coated hydroxyapatite implants are of good choice in posterior maxilla and they can be early loaded.

Assessment of Marginal Bone Loss of Early Loaded Nano Coated Hydroxyapatite Implants in Posterior Maxilla

Assessment of Marginal Bone Loss of Early Loaded Nano Coated Hydroxyapatite Implants in Posterior Maxilla

Advancements in facial implantology: a review of hydroxyapatite applications and outcomes.

The search for an ideal bone substitute in reconstructive surgery has led to the exploration of various materials, with hydroxyapatite (HaP) emerging as a promising candidate due to its biocompatibility, osteoconductive properties, and structural similarity to human bone. Despite its potential, there is a paucity of data on the long-term safety and efficacy of HaP in facial skeletal reconstruction and augmentation. We conducted a systematic review following PRISMA 2020 guidelines, searching PubMed/MEDLINE, Google Scholar, CENTRAL, and Web of Science databases for studies on hydroxyapatite facial implants in reconstruction and augmentation. Our search yielded 12 studies that met our inclusion criteria, encompassing 74 patients treated with HaP implants for various indications including facial fractures/defects, aesthetic facial balancing, and after tumor resection. The studies reported on outcomes such as implant integration, complications, aesthetic results, and patient satisfaction, with a general trend indicating positive outcomes for the use of HaP in facial reconstruction. Hydroxyapatite appears to be a viable and effective material for facial skeletal reconstruction and augmentation, offering benefits in terms of biocompatibility, osteoconductivity, and patient outcomes. However, limitations such as low mechanical strength and the need for further research on long-term safety and efficacy were identified. This review underscores the potential of HaP in craniofacial surgery while highlighting areas for future investigation.

Bone-inspired hydroxyapatite nanowire-based bioceramics with superior mechanical performance

The fabrication of hydroxyapatite (HAP)-based bioceramics with similar mechanical performance to bone by traditional sintering process is still challenge. In bone tissues, HAP mineralized collagen fibrils and fiber-oriented microstructure play key roles in superior mechanical performance of bone. Inspired by the fiber-oriented microstructure and biomineralization process of bone, the mineralized HAP-based bioceramics (M-HAP) are successfully fabricated via directional assembly and biomimetic mineralization strategies based on ultralong HAP nanowires. The M-HAP bioceramics show comparable mechanical performance to human cortical bone in terms of flexural strength, tensile strength, Young's modulus and hardness, which could overcome the issue of mismatched mechanical properties between traditional HAP implants and host bone. In addition, the M-HAP bioceramics also exhibit good cytocompatibility in vitro and no obvious inflammatory response after implantation in vivo. Such bone-inspired bioceramics with both high mechanical property and good biocompatibility have great potential in the field of bone regeneration.

Synthetic and Biological-Derived Hydroxyapatite Implant Coatings

Bone and joint defects or diseases, coupled with edentation, pose challenging and commonly encountered clinical issues with a significant incidence in the medical domain [...]

An Investigation into the Relative Efficacy of High-Velocity Air-Fuel-Sprayed Hydroxyapatite Implants Based on the Crystallinity Index, Residual Stress, Wear, and In-Flight Powder Particle Behavior.

Due to its resemblance to the bone, hydroxyapatite (HA) has been widely used for bioactive surface modification of orthopedic implants. However, it undergoes significant thermal decomposition and phase transformations at a high operating temperature, leading to premature implant failure. This investigation uses high-velocity air-fuel (HVAF) spray, an emerging low-temperature thermal spray technique, to deposit HA over the Ti-6Al-4V substrate. Coating characteristics, such as the crystallinity index and phase analysis, were measured using X-ray diffraction, Raman analysis, and Fourier transform infrared spectroscopy, residual stress using the sin2ψ method, and tribological performance by a fretting wear test. The coating retained an over 90% crystallinity index, a crystallite size of 41.04 nm, a compressive residual stress of -229 ± 34.5 MPa, and a wear rate of 1.532 × 10-3 mm3 N-1 m-1. Computational in-flight particle traits of HA particles (5 to 60 μm) were analyzed using computational fluid dynamics; it showed that 90% of particles were deposited at a 700 to 1000 m/s velocity and a 900 to 1450 K temperature with a 2.1 ms mean residence time. In-flight particle oxidation was minimized, and particle impact deformation was maximized, which caused severe plastic deformation, forming crystalline, compressive residual stressed coatings. The thermal decomposition model of low-temperature HVAF-sprayed HA particles helped to understand the implants' crystallinity index, residual stress, and tribological characteristics. Hence, this experimental and computational analysis shows that the HVAF process can be a promising candidate for biomedical applications for having strong and durable implants.

The posterior auricular muscle complex graft as a porous orbital implant wrap: long-term follow-up over a 31-year period

ABSTRACT Purpose Orbital implant exposures, infections, and extrusions can occur many years following enucleation or evisceration. This study analyzes complication rates following porous orbital implant wrapped with a posterior auricular muscle complex graft (PAMCG). Methods This is a retrospective study of patients who underwent orbital implantation following enucleation using this technique between 1992 and 2013. Only cases with a minimum of 18 months of follow-up were included. No patients underwent peg implantation. Patient’s demographics, follow-up time, type of implant, complications including wound dehiscence, exposure, postoperative infection, and extrusion were recorded. Results This study included 36 orbits of 36 patients with a mean age of 39.3 ± 23.2 years (range, 3–84 years). Thirty patients had hydroxyapatite implants and six had porous polyethylene. The average follow-up time was 12.6 ± 5.6 years (range, 1.5–31.0 years). There were no implant extrusions, and only one exposure resulting in orbital infection that necessitated implant removal (2.8%). Conclusion Wrapping porous orbital implants with PAMCG had favorable long-term outcomes over a thirty-one-year period.

Longitudinal Comparison of Orbital Volumes from Enucleated Eyes with Hydroxyapatite Orbital Implant in Unilateral Retinoblastoma Patients.

To compare the orbital volume between enucleated and contralateral, uninvolved orbits over a 5-year period in patients with unilateral retinoblastoma who underwent enucleation with hydroxyapatite (HA) implant placement by a single surgeon. A retrospective review was performed on the clinical records and radiographic images of unilateral retinoblastoma patients who underwent enucleation with primary HA implantation from 2003 to 2020 at a single institution. Bilateral orbital volume measurements were taken from the initial postoperative MRI scan and again at 1- and 5-years postenucleation. The main outcome measure was the longitudinal change in volume difference (∆𝑉). The implant size, age at enucleation, and sex were also evaluated. A linear mixed-effect model was used for analysis. A total of 124 patients (73 males) with HA implants following enucleation were included. Overall, the unaffected orbit trended toward having a greater volume compared with the enucleated orbit, but this was not statistically significant (β = 0.003; p = 0.122). The mean age at enucleation was 2.4 years. The median time between enucleation and the initial, 1-year, and 5-year postoperative MRIs was 6 months, 17 months, and 55 months, respectively. There was no statistical correlation between age at enucleation, gender, implant size, or orbital volume at any time points ( p > 0.05). Patients treated with enucleation and primary HA implant placement for unilateral retinoblastoma did not display significant asymmetry in orbital volume on 5-year postenucleation MRIs, suggesting that HA implants promote orbital growth comparable to a nonenucleated orbit in the pediatric population.

INFLUENCE OF MECHANICAL AND THE CORROSION CHARACTERISTICS ON THE SURFACE OF MAGNESIUM HYBRID NANOCOMPOSITES REINFORCED WITH HAp AND rGO AS BIODEGRADABLE IMPLANTS

Magnesium composites stay relevant for the applications of biodegradable implant as they are harmless and possess characteristics such as density and elastic modulus analogous to the cortical bone in humans. But corrosion is one major issue associated with magnesium when the biomedical applications are contemplated. Moreover, load bearing abilities are also required in case of an orthopedic implant. In this study, to achieve the desired implant characteristics, hybrid nanocomposites (HNCs) of Mg–2.5Zn binary alloys such as metal matrix, hydroxyapatite (HAp), and reduced graphene oxide (rGO) as reinforcements were fabricated via the vacuum-assisted stir casting method. The overall weight percentage of the reinforcements was fixed at 3% and both the reinforcements varied in compositions by weight to prepare the samples S0 (Pure Magnesium), S1 (Mg–2.5Zn–0.5HAp–2.5rGO), S2 (Mg–2.5Zn–1.0HAp–2.0rGO), S3 (Mg–2.5Zn–1.5HAp–1.5rGO), S4 (Mg–2.5Zn–2.0HAp–1.0rGO), and S5 (Mg–2.5Zn–2.5HAp–0.5rGO), respectively. The influence of mechanical characteristics such as tensile strength, compressive strength, and microhardness as well as the corrosion over the surface of the nanocomposite in simulated body fluid (SBF) have been assessed for their suitability as biodegradable orthopedic implants. Results suggest that the fabricated nanocomposites exhibit superior characteristics in comparison to pure magnesium. Increasing the HAp from 0.5 wt.% to 2.5 wt.% enhanced the compressive strength and reduced the corrosion rate. On the other hand, increasing the rGO from 0.5 wt.% to 1.5 wt.% increased the tensile strength. The formation of apatite layer over the composites is observed in the SBF solution. Among all the fabricated hybrid nanocomposite samples, the sample S3 (Mg–2.5Zn–1.5HAp–1.5rGO) with equal wt.% of HAp and rGO exhibited 209.60 MPa of ultimate tensile strength, 300.1 MPa of ultimate compressive strength, and a corrosion rate of 0.91 mm/year thus making it the best suited and a prospective material for biodegradable implant application.

Synthesis of Tetraethoxysilane-Reacted Hydroxyapatite Nanoparticles and Their Stabilization in Phosphate-Buffered Saline.

Hydroxyapatite (HA) particle, which is an inorganic component of biological hard tissues, is being applied as a bioceramic for biotechnology and medicine fields. However, early bone formation is difficult in the implantation of well-known stoichiometric HA into our body. To solve this problem, it is important to control the shapes and chemical compositions of the physicochemical properties of HA to be functionalized as the state similar to the biogenic bone. In this study, the physicochemical properties of the HA particles synthesized in the presence of tetraethoxysilane (TEOS) (SiHA particles) were evaluated and investigated. In particular, the surface layers of the SiHA particles were successfully controlled by adding silicate and carbonate ions in the synthetic, which would be involved in the bone formation process, and their elusive reaction behavior with phosphate-buffered saline (PBS) was also evaluated. The results showed that the ions in the SiHA particles increased with the increase in the added TEOS concentration, and the silica oligomer was also formed on the surfaces. The ions were present not only in the HA structures but also on the surface layers, indicating the formation of the non-apatitic layer containing the hydrated phosphate and calcium ions. The change in state of the particles with the immersion in PBS was evaluated, the carbonate ions eluted from the surface layer into PBS, and the free water component in the hydration layer increased with the immersion time in PBS. Therefore, we successfully synthesized the HA particles containing silicate and carbonate ions, suggesting the important state of the surface layer consisting of the characteristic non-apatitic layers. It was found that the ions in the surface layers can react with PBS and leach out, weakening the interaction of hydrated water molecules on the particle surfaces to increase the free water component in the surface layer.

Structural Characterization, Dielectric Properties, Corrosion Resistance, and In Vitro Thrombogenicity of Zinc-Fabricated Hydroxyapatite Implants

Structural Characterization, Dielectric Properties, Corrosion Resistance, and In Vitro Thrombogenicity of Zinc-Fabricated Hydroxyapatite Implants